TANG KEVIN
Follow13F filer, CIK 1178579, SAN DIEGO, CA
TANG KEVIN filed a 13F-NT notice for the quarter ended 2026-09-30 on 2026-11-16.
Accepted , ingested 13F-NT 0001214659-26-014411
This filer reports no holdings of its own for Q3 2026. It filed a 13F-NT notice, and its holdings are in the report of . How notices are handled.
Changes against Q2 2026 are not shown: it was a notice, with the holdings in another manager's report (0 positions on file), so every position would read as new.
Part of the filer group TANG CAPITAL MANAGEMENT LLC
TANG CAPITAL MANAGEMENT LLCTANG CAPITAL PARTNERS III, INC
- TANG CAPITAL MANAGEMENT LLC
- TANG CAPITAL PARTNERS III, INC
- TANG CAPITAL PARTNERS INTERNATIONAL, LP
- TANG CAPITAL PARTNERS IV, INC
- TANG CAPITAL PARTNERS, LP
Stakes and trades reported after 2026-09-30
13D, 13G and Form 4 filings by this filer's group, dated after the 13F period, on securities the quarter does not hold as shares.
- BOLD BOUNDLESS BIO INC: Form 4 bought 39,920 shares on 2026-11-20, 0001178579-26-000026Timeline
Accepted , ingested - BOLD BOUNDLESS BIO INC: Form 4 bought 41,461 shares on 2026-11-19, 0001178579-26-000026Timeline
Accepted , ingested - BOLD BOUNDLESS BIO INC: Form 4 bought 22,231 shares on 2026-11-18, 0001178579-26-000026Timeline
Accepted , ingested - ARDX ARDELYX INC: 13G 14,336,247 shares, 5.7% of the class, 13G filed 2026-11-17, 0001214659-26-014519Timeline
Accepted , ingested - INO INOVIO PHARMACEUTICALS INC: 13G 17,978,200 shares, 9.99% of the class, 13G filed 2026-11-16, 0001214659-26-014444Timeline
Accepted , ingested - EYPT EYEPOINT INC: 13G 8,250,200 shares, 9.6% of the class, 13G filed 2026-10-27, 0001214659-26-013297Timeline
Accepted , ingested - SKYE SKYE BIOSCIENCE INC: 13G 263,560 shares, 6% of the class, 13G filed 2026-10-14, 0001214659-26-012924Timeline
Accepted , ingested - AVIR ATEA PHARMACEUTICALS INC: 13G 4,814,700 shares, 6% of the class, 13G filed 2026-10-06, 0001214659-26-012604Timeline
Accepted , ingested
How Q3 2026 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-NT 0001214659-26-014411 | notice | 2026-11-16 |